None listed
Conditions
Interventions
Dietary Supplement : Subjucts will be randomized to receive experimental group or placebo group. They will orally self-administer Cordyceps militaris or placebo, 2 times per day, 2 tablets per time fo
Sponsors
Bundang Jesaeng Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Male and Female aged over 19 years (2) Subject who had histologically and radiologically confirmed diagnosis of malignant neoplasm (3) Subject who will receive or have been received radiotherapy over 2 weeks. Or subject who is resting chemotherapy (4) Subject who agrees to participate in the study and signs the informed consent form
Exclusion criteria
Exclusion criteria: (1) Subject with acute diseases or severe infections, such as pneumonia, sepsis, shock (2) Patients with severely impaired organ system such as heart failure, hepatic failure, renal failure (3) Subject with Cordyceps militaris hypersensitiveness in current or past history (4) Inappropriate subject decided by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NK cell activity, NK cell count, Immune cell proliferation, Cytokine cluster (IL-2, INF-?) | — |
Secondary
| Measure | Time frame |
|---|---|
| Body composition (protein mass, boby fat mass, muscle mass, skeletal muscle mass);Quality of life in cancer patients;Complication incidence;Adverse Event;clinical laboratory test(CBC/blood chemistry test);vital sign(pulse, blood pressure);physical measurement(weight);Vitamin D | — |
Countries
Korea, Republic of
Contacts
Public ContactDoori Choi
Bundang Jesaeng Hospital
Outcome results
None listed